A detailed history of Beacon Pointe Advisors, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 2,027 shares of DGX stock, worth $277,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,027
Previous 3,228 37.21%
Holding current value
$277,881
Previous $429,000 35.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$125.91 - $144.34 $151,217 - $173,352
-1,201 Reduced 37.21%
2,027 $277,000
Q1 2024

May 14, 2024

BUY
$123.78 - $142.11 $42,951 - $49,312
347 Added 12.04%
3,228 $429,000
Q4 2023

Feb 08, 2024

SELL
$120.62 - $141.12 $82,142 - $96,102
-681 Reduced 19.12%
2,881 $397,000
Q3 2023

Nov 14, 2023

BUY
$121.86 - $144.92 $137,823 - $163,904
1,131 Added 46.52%
3,562 $434,000
Q2 2023

Aug 11, 2023

SELL
$130.56 - $146.84 $10,444 - $11,747
-80 Reduced 3.19%
2,431 $341,000
Q1 2023

May 12, 2023

BUY
$131.53 - $155.76 $4,603 - $5,451
35 Added 1.41%
2,511 $355,000
Q4 2022

Feb 14, 2023

SELL
$123.31 - $157.26 $264,130 - $336,850
-2,142 Reduced 46.38%
2,476 $387,000
Q3 2022

Nov 09, 2022

BUY
$121.77 - $141.1 $240,861 - $279,095
1,978 Added 74.92%
4,618 $566,000
Q2 2022

Aug 11, 2022

SELL
$127.07 - $145.39 $973,102 - $1.11 Million
-7,658 Reduced 74.36%
2,640 $351,000
Q1 2022

May 17, 2022

BUY
$129.09 - $164.35 $1.33 Million - $1.69 Million
10,298 New
10,298 $1.41 Million
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $385,288 - $474,912
-2,745 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $38,023 - $45,188
286 Added 11.63%
2,745 $399,000
Q2 2021

Aug 17, 2021

BUY
$126.66 - $141.48 $311,456 - $347,899
2,459 New
2,459 $325,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.